Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Sell
18
RZLT Quote, Financials, Valuation and Earnings
Last price:
$3.04
Seasonality move
:
8.36%
Day range:
$3.00 - $3.14
52-week range:
$1.89 - $6.19
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.85x
Volume:
519.3K
Avg. volume:
464.7K
1-year change:
58.85%
Market cap:
$184.6M
Revenue:
--
EPS (TTM):
-$1.22
Analysts' Opinion
-
Consensus RatingRezolute has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $13.11, Rezolute has an estimated upside of 329.87% from its current price of $3.05.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $9.00 representing 100% downside risk from its current price of $3.05.
Fair Value
-
According to the consensus of 7 analysts, Rezolute has 329.87% upside to fair value with a price target of $13.11 per share.
RZLT vs. S&P 500
-
Over the past 5 trading days, Rezolute has underperformed the S&P 500 by -15.71% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Rezolute does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Rezolute has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Rezolute reported revenues of --.
Earnings Growth
-
Rezolute has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Rezolute reported earnings per share of -$0.22.
Enterprise value:
88.1M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.39x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$46.7M | -$62.5M | -$73.3M | -$15.2M | -$17.1M | |
| EBITDA | -$44.3M | -$62.4M | -$73.3M | -$15.2M | -$17.1M | |
| Diluted EPS | -$1.50 | -$1.10 | -$1.22 | -$0.27 | -$0.22 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $38.2M | $78.1M | $147.6M | $96.1M | $98.7M | |
| Total Assets | $38.9M | $83.4M | $150.2M | $102.2M | $112M | |
| Current Liabilities | $2.7M | $6.4M | $6.3M | $8M | $10.6M | |
| Total Liabilities | $3M | $21.1M | $8.9M | $10.4M | $12.4M | |
| Total Equity | $35.9M | $62.3M | $141.3M | $91.7M | $99.6M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$41.2M | -$53M | -$63.4M | -$13M | -$13.7M | |
| Cash From Investing | -$153K | -$80.9M | -$9.6M | $17.8M | $11.5M | |
| Cash From Financing | $105.7M | -$293K | $69.5M | -$293K | $657K | |
| Free Cash Flow | -$41.3M | -$53M | -$63.4M | -$13M | -$13.7M | |
RZLT
Sector
Market Cap
$184.6M
$39.2M
Price % of 52-Week High
49.31%
45.93%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.81%
1-Year Price Total Return
58.85%
-38.63%
Beta (5-Year)
0.952
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$3.43
200-day SMA
Sell
Level
$4.71
Bollinger Bands (100)
Sell
Level
4.18 - 5.44
Chaikin Money Flow
Buy
Level
2.2M
20-day SMA
Sell
Level
$3.87
Relative Strength Index (RSI14)
Sell
Level
24.55
ADX Line
Sell
Level
29.13
Williams %R
Buy
Level
-95.6522
50-day SMA
Sell
Level
$4.51
MACD (12, 26)
Sell
Level
-0.40
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Neutral
Level
20.7M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
Stock Forecast FAQ
In the current month, RZLT has received 7 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RZLT average analyst price target in the past 3 months is $13.11.
-
Where Will Rezolute Stock Be In 1 Year?
According to analysts, the consensus estimate is that Rezolute share price will rise to $13.11 per share over the next 12 months.
-
What Do Analysts Say About Rezolute?
Analysts are divided on their view about Rezolute share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Rezolute is a Sell and believe this share price will drop from its current level to $9.00.
-
What Is Rezolute's Price Target?
The price target for Rezolute over the next 1-year time period is forecast to be $13.11 according to 7 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is RZLT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Rezolute is a Buy. 7 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of RZLT?
You can purchase shares of Rezolute via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Rezolute shares.
-
What Is The Rezolute Share Price Today?
Rezolute was last trading at $3.04 per share. This represents the most recent stock quote for Rezolute. Yesterday, Rezolute closed at $3.05 per share.
-
How To Buy Rezolute Stock Online?
In order to purchase Rezolute stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Is Shopify a Millionaire Maker?
Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
